ABSIAbsci Corporation Common Stock
9.550USD-4.40%Mkt Cap: 1.64B $P/E: —3d ago
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.64B $
Enterprise Value1.40B $
Revenue (TTM)1.56M $
Gross Profit-84.23M $
Net Income (TTM)-115.18M $
Revenue/Share0.0100 USD
Last Price9.550 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees140
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-13.74
PEG—
EV/EBITDA-11.68
EV/Revenue893.83
P/S1020.23
P/B6.47
EPS (TTM)-0.73
EPS (Forward)-0.68
52W Range
2.24075% of range12.00
52W High12.00 USD
52W Low2.240 USD
Profitability
Gross Margin0.00%
Oper. Margin-10741.51%
EBITDA Margin0.00%
Profit Margin-4113.68%
ROE-60.80%
ROA-53.25%
Growth
Revenue Growth-46.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-92.92M $
CapEx (TTM)1.11M $
FCF Margin-3240.98%
FCF Yield-3.09%
Net Debt-197.31M $
Net Debt/EBITDA1.65
Balance Sheet
Debt/Equity0.03
Current Ratio10.63
Quick Ratio10.26
Book Value/Sh1.435 USD
Cash/Share1.172 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.89 USD
Upside (mean)+45.4%
Target Range10.00 USD – 17.00 USD
$10.00+45.4% to mean$17.00
# Analysts9
Ownership
Shares Out.171.61M
Float163.81M
Insiders11.85%
Institutions87.07%
Short Interest
Short Ratio9.5d
Short % Float26.87%
Short % Out.22.02%
Shares Short37.31M
Short (prev mo.)36.94M
Technical
SMA 508.946 (+6.8%)
SMA 2004.963 (+92.4%)
Beta2.42
S&P 52W Chg18.16%
Avg Vol (30d)3.33M
Avg Vol (10d)2.89M
Technical Indicators
RSI (14)58.0
MACD0.3412
MACD Signal0.2251
MACD Hist.+0.1161
BB Upper10.25 USD
BB Middle8.501 USD
BB Lower6.753 USD
BB Width41.12%
ATR (14)0.6896 USD
Vol Ratio (20d)0.87x